Lacril
U$D 33.10
Out of stock
Usage Indications
LACRIL; ACUTE AND CHRONIC ARTHRITIS; HIGH MOLECULAR; WEIGHT Intra-articular inflammatory processes tend to degrade the sodium hyaluronate present in the affected joint. Due to its high molecular weight and appropriate viscosity—unlike other low-molecular-weight products—Lacril rapidly and naturally restores the altered synovial fluid to normal; FORMULA; Each syringe contains:; Hyaluronic acid (sodium salt)............20 mg; Excipient q.s. ..................................... 2 ml; CLINICAL INDICATIONS FOR USE; Indicated for the treatment of intra-articular diseases in horses. Arthritis, osteoarthritis, osteochondrosis, synovitis, post-intra-articular surgery, post-intra-articular lavage, tendinitis; ROUTES OF ADMINISTRATION AND DOSAGE; Intra-articular route: small and medium joints 2 ml (20 mg), large joints 4 ml (40 mg). Multiple joints may be treated simultaneously. Treatment may be repeated weekly, at the discretion of the attending veterinarian; Intratendinous route: at the center of the lesion, preferably under ultrasound guidance; CONTRAINDICATIONS; At the recommended doses, there are no known contraindications; PRECAUTIONS AND WARNINGS; The injection must be administered under strictly aseptic conditions, taking care not to damage the articular cartilage with the needle tip. Transient, short-lived local reactions (heat, swelling, pain) may occur, as with the use of any intra-articular medication. For best results, horses should rest for 2 to 3 days after treatment before resuming physical activity
Specifications
General product specifications and details
Laboratory
Farm Animal
Categories
Osteoarticular Regenerators
GMP Certificate
Not specified
Doping
Negative / Doping free